首页> 美国卫生研究院文献>International Journal of Neuropsychopharmacology >Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials

【2h】

Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials

机译：在轻度认知障碍和阿尔茨海默氏病中通过抗痴呆药预防脑萎缩的研究：纵向随机安慰剂对照试验的荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background:There has not been conclusive evidence for prevention of brain atrophy by anti-dementia drugs in mild cognitive impairment and Alzheimer’s Disease.

机译：背景：目前尚无确凿证据表明在轻度认知障碍和阿尔茨海默氏病中使用抗痴呆药物预防脑萎缩。

著录项

期刊名称 International Journal of Neuropsychopharmacology
作者
Taro Kishi; Shinji Matsunaga; Kazuto Oya; Toshikazu Ikuta; Nakao Iwata;
展开▼
作者单位

展开▼
年(卷),期 2015(18),12
年度 2015
页码 pyv070
总页数 7
原文格式 PDF
正文语种
中图分类神经科学;药学;神经病学;精神病学;
关键词
brain atrophy mild cognitive impairment/Alzheimer’s Disease magnetic resonance imaging meta-analysis anti-dementia drugs;

机译：脑萎缩;轻度认知障碍/阿尔茨海默氏病;磁共振成像;荟萃分析;抗痴呆药;

相似文献

外文文献
中文文献
专利

1. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials [J] . Kazuto Oya, Nakao Iwata, Shinji Matsunaga, The international journal of neuropsychopharmacology . 2015,第12期

机译：在轻度认知障碍和阿尔茨海默氏病中通过抗痴呆药物预防脑萎缩：纵向随机安慰剂对照试验的荟萃分析
2. Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials [J] . Kishi Taro, Matsunaga Shinji, Oya Kazuto, The international journal of neuropsychopharmacology . 2015,第12期

机译：在轻度认知障碍和阿尔茨海默氏病中通过抗痴呆药物预防脑萎缩：纵向随机安慰剂对照试验的荟萃分析
3. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial [J] . Takehiko Fujino, Tatsuo Yamada, Takashi Asada, EBioMedicine . 2017,第4期

机译：轻度阿尔茨海默氏病和轻度认知障碍患者口服血浆生成素的疗效和血液中血浆血浆生成素的变化：多中心，随机，双盲，安慰剂对照试验
4. Increasing Power to Predict Mild Cognitive Impairment Conversion to Alzheimer's Disease Using Hippocampal Atrophy Rate and Statistical Shape Models [C] . Kelvin K. Leung, Kai-Kai Shen, Josephine Barnes, International conference on medical image computing and computer-assisted intervention;MICCAI 2010 . 2010

机译：使用海马萎缩率和统计形状模型来预测轻度认知障碍转换为阿尔茨海默氏病的能力不断增强
5. Oxidative stress in brain in mild cognitive impairment and early Alzheimer's disease: Implications for the progression of Alzheimer's disease. [D] . Reed, Tanea Tylette. 2007

机译：轻度认知障碍和早期阿尔茨海默氏病在大脑中的氧化应激：对阿尔茨海默氏病进展的影响。
6. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimers Disease and Mild Cognitive Impairment: A Multicenter Randomized Double-blind Placebo-controlled Trial [O] . Takehiko Fujino, Tatsuo Yamada, Takashi Asada, 2017

机译：轻度阿尔茨海默氏病和轻度认知障碍患者口服血浆生成素的疗效和血中血浆生成素变化：多中心随机双盲安慰剂对照试验
7. Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial [O] . Takehiko Fujino, Tatsuo Yamada, Takashi Asada, 2017

机译：口服施用缩醛磷脂治疗轻度阿尔茨海默病和轻度认知障碍患者的疗效和血浆原胶原变化：多中心，随机，双盲，安慰剂对照试验

Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer’s Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled Trials

摘要

著录项

相似文献

相关主题

期刊订阅